News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wallace Owen B.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/04/2023 |
4
| Wallace Owen B. (Chief Scientific Officer) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $7.78, valued at
$1.1M
|
|
| 03/02/2022 |
4
| Wallace Owen B. (Chief Scientific Officer) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Granted 117,450 options to buy
@ $13.41, valued at
$1.6M
|
|
| 06/25/2021 |
4
| Wallace Owen B. (Chief Scientific Officer) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Granted 387,069 options to buy
@ $0
Granted 113,298 options to buy
@ $19, valued at
$2.2M
|
|
| 06/23/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/14/2020 |
4
| Wallace Owen B. (Chief Scientific Officer) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Exercised 6,350 options to buy
@ $7.84, valued at
$49.8k
|
|
| 07/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2020 |
4
| Wallace Owen B. (Chief Scientific Officer) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 2,232 shares
@ $20, valued at
$44.6k
Exercised 2,232 options to buy
@ $7.84, valued at
$17.5k
|
|
| 05/29/2020 |
4
| Wallace Owen B. (Chief Scientific Officer) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 448 shares
@ $20, valued at
$9k
Exercised 448 options to buy
@ $7.84, valued at
$3.5k
|
|
| 05/28/2020 |
4
| Wallace Owen B. (Chief Scientific Officer) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Sold 412 shares
@ $20, valued at
$8.2k
Exercised 412 options to buy
@ $7.84, valued at
$3.2k
|
|
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2020 |
4
| Wallace Owen B. (Chief Scientific Officer) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Granted 58,900 options to buy
@ $16.87, valued at
$993.6k
|
|
| 07/18/2019 |
4
| Wallace Owen B. (Chief Scientific Officer) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Granted 44,493 options to buy
@ $16, valued at
$711.9k
|
|
| 07/17/2019 |
3
| Wallace Owen B. (Chief Scientific Officer) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
|
|